Clinically validated with confirmed telomere lengthening and used in Japanese medical institutions and IV therapies, this product supports distributor wellness portfolios with a 95% repeat rate.
Japan, 3rd Mar 2026 – Asa Pharmaceutical Co., Ltd. (Headquarters: Minato Ward, Tokyo; President and CEO: Tomoko Iwase), a manufacturer and distributor of health supplements, announced that effective Monday, January 26, 2026, it will significantly strengthen its supply structure for the Japanese-made NMN supplement NMN KIWAMI in the North American market and will officially begin accepting applications for local sales distributors.
NMN KIWAMI is sold exclusively through medical institutions in Japan due to its high quality and is also used as a raw material for NMN intravenous therapy, positioning it as a professional-use product. With a repeat purchase rate reaching 95%, NMN KIWAMI enters the rapidly expanding U.S. longevity market as a uniquely positioned supplement that combines advanced Japanese manufacturing standards with full compliance with U.S. regulatory requirements, aiming to expand market share in collaboration with strategic local partners.
Four Reasons Why U.S. Distributors Should Choose NMN KIWAMI
1. Exceptional Compliance and Safety (FDA & Informed Sport)
Regulatory compliance represents the highest barrier in the U.S. supplement market. NMN KIWAMI uses domestically produced raw materials that meet FDA standards and has obtained Informed Sport certification, which complies with World Anti-Doping Agency (WADA) guidelines. This allows distributors serving professional athletes and celebrities to add the product to their portfolios with confidence.
2. Reliability Based on Clinical Evidence
Human clinical trials involving subjects aged 50 to 61 demonstrated improvements in insulin resistance and triglyceride levels, as well as confirmed lengthening of telomeres, a key biomarker of aging. These data provide strong appeal to evidence-driven, high-income consumer segments in the United States.
3. Made in Japan Quality and Advanced Delivery Technology
100% pure Japanese NMN: A proprietary manufacturing process achieves high NMN content per capsule with zero impurities.
Acid-resistant HPMC capsules: Designed to protect NMN from gastric acid and deliver it efficiently to the small intestine.
PTP blister packaging: Maintains NMN quality at the highest level until the moment of opening.
4. Presentation at the Japanese Society of Anti-Aging Medicine and Medical Supervision
Supervised by Dr. Hibino, a leading authority in anti-aging medicine, NMN KIWAMI research findings have been presented at the Annual Meeting of the Japanese Society of Anti-Aging Medicine. This academic-level validation makes the product suitable for wellness clinics, spas, and premium fitness chains.
Support Structure for Local Distributors
Stable supply: Enhanced in-house production enables flexible response to large-volume orders
Marketing support: Provision of clinical data, high-resolution product visuals, and physician endorsement comments
Exclusive distribution considerations: Discussions regarding regional exclusivity based on performance and territory
Logistics optimization: Documentation support for international shipping, including certificates of origin
Comment from President and CEO Tomoko Iwase
“Japanese precision manufacturing can deliver new value to health-conscious consumers in the United States. NMN KIWAMI represents not just a supplement, but a science-based approach to well-aging. Collaboration with U.S. partners who share this vision will help shape the next generation of the wellness market.”
US FDA Certification
NMN KIWAMI Premium supplements package sample
NMN KIWAMI by Asa Pharmaceutical
Media Contact
Organization: Asa Pharmaceutical Co., Ltd.
Contact Person: Tomoko Iwase
Website: https://asapharma.jp/en/
Email: Send Email
Address:1-3-9 Azabu-Juban, Minato-ku, Tokyo 106-0045
Country:Japan
Release id:42094
The post Premium Supplement NMN KIWAMI Made in Japan with FDA Compliance Seeks Strategic U.S. Distribution Partnerships appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Encore journalist was involved in the writing and production of this article.
